[go: up one dir, main page]

PL3774862T3 - Nowe analogi glp-1 - Google Patents

Nowe analogi glp-1

Info

Publication number
PL3774862T3
PL3774862T3 PL19724915.4T PL19724915T PL3774862T3 PL 3774862 T3 PL3774862 T3 PL 3774862T3 PL 19724915 T PL19724915 T PL 19724915T PL 3774862 T3 PL3774862 T3 PL 3774862T3
Authority
PL
Poland
Prior art keywords
analogues
novel glp
glp
novel
Prior art date
Application number
PL19724915.4T
Other languages
English (en)
Inventor
Rajamannar Thennati
Nishith Chaturvedi
Vinod Sampatrao BURADE
Pradeep Dinesh SHAHI
Muthukumaran Natarajan
Ravishankara Madavati NAGARAJA
Rishit Mansukhlal ZALAWADIA
Kunal PANDYA
Brijeshkumar PATEL
Dhiren Rameshchandra JOSHI
Krunal Harishbhai SONI
Abhishek Tiwari
Vipulkumar Shankarbhai PATEL
Original Assignee
Sun Pharmaceutical Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Limited filed Critical Sun Pharmaceutical Industries Limited
Publication of PL3774862T3 publication Critical patent/PL3774862T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transmission And Conversion Of Sensor Element Output (AREA)
PL19724915.4T 2018-04-05 2019-04-05 Nowe analogi glp-1 PL3774862T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN201821013109 2018-04-05
IN201821040474 2018-10-26
IN201821040468 2018-10-26
PCT/IB2019/052835 WO2019193576A1 (en) 2018-04-05 2019-04-05 Novel glp-1 analogues

Publications (1)

Publication Number Publication Date
PL3774862T3 true PL3774862T3 (pl) 2022-10-03

Family

ID=66589592

Family Applications (2)

Application Number Title Priority Date Filing Date
PL19724915.4T PL3774862T3 (pl) 2018-04-05 2019-04-05 Nowe analogi glp-1
PL22177403.7T PL4122954T3 (pl) 2018-04-05 2019-04-05 Nowe analogi GLP-1

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL22177403.7T PL4122954T3 (pl) 2018-04-05 2019-04-05 Nowe analogi GLP-1

Country Status (31)

Country Link
US (7) US11447535B2 (pl)
EP (3) EP3774862B1 (pl)
JP (2) JP7250814B2 (pl)
KR (1) KR20200141469A (pl)
CN (2) CN117964735A (pl)
AU (2) AU2019247936C1 (pl)
BR (1) BR112020020419A2 (pl)
CA (1) CA3095988A1 (pl)
CL (1) CL2020002574A1 (pl)
CO (1) CO2020012425A2 (pl)
DK (2) DK4122954T3 (pl)
EC (1) ECSP20070185A (pl)
ES (2) ES2980707T3 (pl)
FI (1) FI4122954T3 (pl)
HR (2) HRP20221054T1 (pl)
HU (2) HUE060135T2 (pl)
IL (1) IL277483A (pl)
JO (1) JOP20200251A1 (pl)
LT (2) LT3774862T (pl)
MX (2) MX2020010505A (pl)
PE (1) PE20211417A1 (pl)
PH (1) PH12020551591A1 (pl)
PL (2) PL3774862T3 (pl)
PT (2) PT4122954T (pl)
RS (2) RS63523B1 (pl)
SG (1) SG11202009467YA (pl)
SI (2) SI3774862T1 (pl)
SM (2) SMT202200352T1 (pl)
UA (1) UA128210C2 (pl)
WO (1) WO2019193576A1 (pl)
ZA (1) ZA202306729B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS63523B1 (sr) * 2018-04-05 2022-09-30 Sun Pharmaceutical Ind Ltd Novi glp-1 analozi
TWI829687B (zh) 2018-05-07 2024-01-21 丹麥商諾佛 儂迪克股份有限公司 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物
TW202216746A (zh) * 2020-06-22 2022-05-01 印度商太陽製藥工業有限公司 長效型ｇｌｐ－１／ｇｉｐ雙重促效劑
CN116171164A (zh) * 2020-10-17 2023-05-26 太阳医药工业有限公司 Glp-1/gip双重激动剂
CN114685646B (zh) * 2020-12-31 2023-04-07 厦门赛诺邦格生物科技股份有限公司 一种多肽侧链类似物的制备方法及其应用
KR20240118914A (ko) 2021-01-20 2024-08-05 바이킹 테라퓨틱스 인코포레이티드 대사 및 간 질환 치료를 위한 조성물 및 방법
JP2024544920A (ja) 2021-11-10 2024-12-05 アイ２オー セラピューティクス，インク． イオン液体組成物
CN115785249B (zh) * 2022-10-13 2023-07-21 江苏师范大学 一类glp-1类似物及其应用
WO2024252366A1 (en) 2023-06-09 2024-12-12 Sun Pharmaceutical Industries Limited Glp-1/gip dual, glp-1/gcg dual and glp-1/gip/gcg triple receptor agonists
WO2024261580A1 (en) 2023-06-20 2024-12-26 Sun Pharmaceutical Industries Limited Glp-1 analog for use in the treatment of metabolic disorders
CN117756914B (zh) * 2023-12-15 2024-09-03 瀚晖制药有限公司 依柯胰岛素的制备方法

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849708B1 (en) 1986-05-05 2005-02-01 The General Hospital Corporation Insulinotropic hormone and uses thereof
US6268343B1 (en) 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
DE122009000079I2 (de) 1996-08-30 2011-06-16 Novo Nordisk As Novo Alle Glp-1 derivate
WO1999043707A1 (en) 1998-02-27 1999-09-02 Novo Nordisk A/S N-terminally modified glp-1 derivatives
EP1060191B1 (en) 1998-02-27 2010-04-28 Novo Nordisk A/S Derivatives of glp-1 analogs
EP1056775B1 (en) 1998-02-27 2010-04-28 Novo Nordisk A/S Glp-1 derivatives of glp-1 and exendin with protracted profile of action
JP2002508162A (ja) 1998-02-27 2002-03-19 ノボ ノルディスク アクティーゼルスカブ Ｎ末端を短縮したｇｌｐ−１誘導体
FR2777283B1 (fr) 1998-04-10 2000-11-24 Adir Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2000034331A2 (en) 1998-12-07 2000-06-15 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Analogues of glp-1
DE60137876D1 (de) 2000-06-16 2009-04-16 Lilly Co Eli Analoge des Glucagon-ähnlichen Peptids-1
ES2311560T3 (es) 2000-12-07 2009-02-16 Eli Lilly And Company Proteinas de fusion glp-1.
BR0306706A (pt) 2002-01-08 2007-03-27 Lilly Co Eli peptìdeo glp-1 estendido, métodos de estimulação do receptor de glp-1 em um indivìduo necessitando de normalização de glicose sanguìnea, de tratamento de um indivìduo profilaticamente para diabetes independente de insulina, de redução ou de manutenção do peso corporal, de tratamento da obesidade, e de tratamento de doenças, em um indivìduo necessitando do mesmo, uso de um composto de glp-1, processo de preparação de uma formulação farmacêutica, e, formulação farmacêutica
JPWO2004037859A1 (ja) 2002-10-11 2006-02-23 株式会社三和化学研究所 Ｇｌｐ−１誘導体及びその経粘膜吸収型製剤
WO2004078777A2 (en) 2003-03-04 2004-09-16 Biorexis Pharmaceutical Corporation Dipeptidyl-peptidase protected proteins
CA2525574C (en) 2003-05-15 2015-06-30 Trustees Of Tufts College Stable analogs of peptide and polypeptide therapeutics
TW200526254A (en) 2003-09-19 2005-08-16 Novo Nordisk As Novel GLP-1 derivatives
CA2551039C (en) 2003-12-16 2013-01-29 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R Analogues of glp-1
US7893017B2 (en) 2004-10-07 2011-02-22 Novo Nordisk A/S Protracted GLP-1 compounds
US8603972B2 (en) 2005-03-18 2013-12-10 Novo Nordisk A/S Extended GLP-1 compounds
TWI362392B (en) * 2005-03-18 2012-04-21 Novo Nordisk As Acylated glp-1 compounds
WO2006121860A2 (en) 2005-05-06 2006-11-16 Bayer Pharmaceuticals Corporation Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use
US8318668B2 (en) 2005-09-08 2012-11-27 Trustees Of Tufts College Stabilized GLP-1 analogs
DK1767545T3 (da) 2005-09-22 2010-03-15 Biocompatibles Uk Ltd GLP-1 (Glucagon-lignende peptid-1)-fusionspolypeptider med forøget peptidaseresistens
EP2190460B1 (en) 2007-09-05 2014-12-17 Novo Nordisk A/S Peptides derivatized with a-b-c-d- and their therapeutical use
EP2214691B1 (en) 2007-10-30 2015-09-30 Indiana University Research and Technology Corporation Compounds exhibiting glucagon antagonist and glp-1 agonist activity
ES2625735T3 (es) 2009-12-16 2017-07-20 Novo Nordisk A/S Análogos y derivados de GLP-1
RU2531590C2 (ru) 2010-04-27 2014-10-20 Бета Фармасьютикалс,Ко,Лтд. Аналоги глюкагоноподобного пептида-1 и их применение
WO2012016419A1 (zh) 2010-08-06 2012-02-09 浙江贝达药业有限公司 Glp-1衍生物及其应用
US9708383B2 (en) 2010-11-09 2017-07-18 Novo Nordisk A/S Double-acylated GLP-1 derivatives
KR101972836B1 (ko) 2011-04-12 2019-04-29 노보 노르디스크 에이/에스 이중 아실화된 ｇｌｐ-1 유도체
WO2012150503A2 (en) 2011-05-03 2012-11-08 Zealand Pharma A/S Glu-glp-1 dual agonist signaling-selective compounds
EP2753642B8 (en) 2011-09-06 2017-12-13 Novo Nordisk A/S Glp-1 derivatives
EP2578599A1 (en) 2011-10-07 2013-04-10 LanthioPep B.V. Cyclic analogs of GLP-1 and GLP-1 related peptides
CN104411322B (zh) 2012-05-08 2017-05-24 诺和诺德股份有限公司 双酰化glp‑1衍生物
WO2013167454A1 (en) 2012-05-08 2013-11-14 Novo Nordisk A/S Double-acylated glp-1 derivatives
JP2015525226A (ja) 2012-06-14 2015-09-03 サノフイ エキセンディン−４ペプチドアナログ
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
TWI617574B (zh) 2012-12-11 2018-03-11 梅迪繆思有限公司 用於治療肥胖之升糖素與ｇｌｐ－１共促效劑
PE20151239A1 (es) 2012-12-21 2015-09-08 Sanofi Sa Derivados de exendina-4 funcionalizada
ES2646538T3 (es) 2013-06-20 2017-12-14 Novo Nordisk A/S Derivados de GLP-1 y sus usos
US9738697B2 (en) 2013-06-23 2017-08-22 Wisconsin Alumni Research Foundation Alpha/beta-polypeptide analogs of glucagon-like peptide-1
US9498534B2 (en) 2013-07-04 2016-11-22 Novo Nordisk A/S Derivatives of GLP-1 like peptides, and uses thereof
US10266577B2 (en) 2013-08-15 2019-04-23 Novo Nordisk A/S GLP-1 derivatives, and uses thereof
EA034322B1 (ru) * 2013-10-17 2020-01-28 Зилэнд Фарма А/С Ацилированные аналоги глюкагона
WO2015086731A1 (en) 2013-12-13 2015-06-18 Sanofi Exendin-4 peptide analogues as dual glp-1/glucagon receptor agonists
EP3080153A2 (en) 2013-12-13 2016-10-19 Medimmune Limited Protease resistant peptides
WO2015086733A1 (en) 2013-12-13 2015-06-18 Sanofi Dual glp-1/glucagon receptor agonists
CN106999602B (zh) 2014-11-27 2022-02-01 诺和诺德股份有限公司 Glp-1衍生物及其用途
CN107108714B (zh) 2014-12-17 2022-02-08 诺和诺德股份有限公司 Glp-1衍生物及其用途
TWI726889B (zh) 2015-06-10 2021-05-11 英商梅迪繆思有限公司 蛋白酶抗性之脂化肽
WO2017035432A1 (en) 2015-08-26 2017-03-02 Robert Doyle Coagonists of glucagon-like peptide 1 receptor and neuropeptide y2 receptor
ES2835033T3 (es) 2016-03-03 2021-06-21 Novo Nordisk As Derivados de GLP-1 y sus usos
EP3468987A2 (en) 2016-06-09 2019-04-17 Medimmune Limited Protease-resistant mono-lipidated peptides
CN109922835B (zh) 2016-11-07 2023-08-04 诺和诺德股份有限公司 Peg化合物的dchbs活性酯及其用途
AR110301A1 (es) 2016-12-02 2019-03-13 Sanofi Sa Compuestos como agonistas peptídicos de receptores de glp1 / glucagón / gip
WO2018178796A1 (en) * 2017-03-27 2018-10-04 Sun Pharmaceutical Industries Limited Method for making kex1 protease sensitive polypeptides using yeast strain
PL3704143T3 (pl) 2018-03-09 2024-04-15 Fresenius Kabi Ipsum S.R.L. Chemo-enzymatyczna synteza liraglutydu, semaglutydu i glp-1
RS63523B1 (sr) * 2018-04-05 2022-09-30 Sun Pharmaceutical Ind Ltd Novi glp-1 analozi

Also Published As

Publication number Publication date
ES2980707T3 (es) 2024-10-02
SI3774862T1 (sl) 2022-10-28
KR20200141469A (ko) 2020-12-18
US20200362007A1 (en) 2020-11-19
CL2020002574A1 (es) 2021-06-04
WO2019193576A1 (en) 2019-10-10
SI4122954T1 (sl) 2024-07-31
MX2020010505A (es) 2021-01-15
US11866477B2 (en) 2024-01-09
PT4122954T (pt) 2024-06-05
PL4122954T3 (pl) 2024-08-12
CN117964735A (zh) 2024-05-03
LT4122954T (lt) 2024-06-25
EP4364751A3 (en) 2024-06-26
PT3774862T (pt) 2022-09-05
AU2019247936C1 (en) 2023-06-15
EP4364751A2 (en) 2024-05-08
US11447535B2 (en) 2022-09-20
EP3774862A1 (en) 2021-02-17
PE20211417A1 (es) 2021-08-02
CO2020012425A2 (es) 2020-12-21
SMT202200352T1 (it) 2022-09-14
EP4122954B1 (en) 2024-04-03
MX2024007688A (es) 2024-07-09
US20210206823A1 (en) 2021-07-08
FI4122954T3 (fi) 2024-06-18
US11242373B2 (en) 2022-02-08
UA128210C2 (uk) 2024-05-08
AU2023203430A1 (en) 2023-06-29
ECSP20070185A (es) 2021-01-29
EP4122954A1 (en) 2023-01-25
JOP20200251A1 (ar) 2020-10-04
US11873328B2 (en) 2024-01-16
ES2925678T3 (es) 2022-10-19
US20240199718A1 (en) 2024-06-20
CA3095988A1 (en) 2019-10-10
JP2021520346A (ja) 2021-08-19
DK3774862T3 (da) 2022-09-05
ZA202306729B (en) 2024-03-27
AU2019247936A1 (en) 2020-10-15
LT3774862T (lt) 2022-09-12
SG11202009467YA (en) 2020-10-29
HUE067499T2 (hu) 2024-10-28
US20220402991A1 (en) 2022-12-22
RS65639B1 (sr) 2024-07-31
SMT202400241T1 (it) 2024-07-09
CN112236444A (zh) 2021-01-15
US20240376175A1 (en) 2024-11-14
JP7250814B2 (ja) 2023-04-03
HRP20240749T1 (hr) 2024-09-13
US20220402992A1 (en) 2022-12-22
JP2023078367A (ja) 2023-06-06
RS63523B1 (sr) 2022-09-30
US20190309040A1 (en) 2019-10-10
HRP20221054T1 (hr) 2022-11-11
US11485766B2 (en) 2022-11-01
HUE060135T2 (hu) 2023-02-28
BR112020020419A2 (pt) 2021-01-19
AU2019247936B2 (en) 2023-03-02
IL277483A (en) 2020-11-30
PH12020551591A1 (en) 2021-08-16
EP3774862B1 (en) 2022-06-08
DK4122954T3 (da) 2024-06-10

Similar Documents

Publication Publication Date Title
IL277483A (en) New anti-GLP-1 analogs
GB202005105D0 (en) n
SG11202105586YA (en) Modified gip peptide analogues
GB2582783B (en) Checkpointing
GB2577682B (en) Auto-injector
GB2589548B (en) Auto-Injector
PL3630806T3 (pl) Analogi peptydów gip o długotrwałym działaniu
GB2575149B (en) Lanyards
GB201800400D0 (en) Structural components
ZA202100322B (en) Polytunnel structure
GB2591977B (en) Auto-Injector
GB202002530D0 (en) N
CA204449S (en) Auto-injector
SMT202300247T1 (it) Inibitori della secrezione proteica a base di triazaciclododecansulfonamide ("tcd")
CA189431S (en) Case
GB202006585D0 (en) n
GB2576916B (en) Polytunnel structure
GB2575634B (en) Polytunnel structure
GB201908550D0 (en) n
GB201818676D0 (en) Polytunnel structure
GB201803158D0 (en) Improved structure